Answers are grounded in this paper and cite their sources.
INTRODUCTION: The human leukocyte antigen G (HLA-G) allele repertoire is crucial for cell-mediated immune responses. While HLA-G's role in human papillomavirus (HPV) infection is increasingly studied, research on HLA-G and humoral immunity remains limited. This study aimed to establish whether HLA-G alleles impact type-specific HPV serological outcomes. METHODS: Altogether, 265 women from the prospective Finnish Family HPV cohort study were included. HLA-G alleles and genotypes were determined by direct DNA-sequencing. Blood samples were collected at baseline (36 weeks of pregnancy) and at 12, 24 and 36 months of follow-up. Antibodies to the L1 antigen of HPV types 6, 11, 16, 18 and 45 were determined using multiplex serology. RESULTS*: Six different HLA-G alleles and genotypes were identified. The most common allele was 01:01:01 (87.2%) followed by *01:01:02 (39.6%). Heterozygote carriage of HLA-G*01:01:01 increased the likelihood of HPV16 seropersistence (OR 2.99; 95%CI 1.13-7.91). Allele *01:01:03 was associated with both increased HPV11 seropositivity (OR 3.93; 95%CI 1.49-10.39) and seropersistence (OR 4.42; 95%CI 1.56-12.49). Conversely, allele *01:04:01 showed a protective association against HPV11 seropositivity (OR 0.43, 95%CI 0.20-0.91). CONCLUSIONS: HLA-G alleles and genotypes may influence seropositivity and seropersistence to L1 antigen of both low-risk HPV11 and high-risk HPV16 genotypes. Given study limitations, these findings should be considered exploratory, and further research is warranted to establish the detailed mechanisms by which HLA-G influences HPV-related humoral immunity and disease outcomes.
No takes yet. Share an insight, caveat, or question.
Anttonen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: